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Objectives: ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally. We car-
ried out a WGS study to understand the genetic background of ESBL-producing KPN in Malawi and place them in
the context of other global isolates.
Methods: We sequenced genomes of 72 invasive and carriage KPN isolates collected from patients admitted to
Queen Elizabeth Central Hospital, Blantyre, Malawi. We performed phylogenetic and population structure analy-
ses on these and previously published genomes from Kenya (n"66) and from outside sub-Saharan Africa
(n"67). We screened for presence of antimicrobial resistance (AMR) genetic determinants and carried out asso-
ciation analyses by genomic sequence cluster, AMR phenotype and time.
Results: Malawian isolates fit within the global population structure of KPN, clustering into the major lineages of
KpI, KpII and KpIII. KpI isolates from Malawi were more related to those from Kenya, with both collections exhib-
iting more clonality than isolates from the rest of the world. We identified multiple ESBL genes, including
blaCTX-M-15, several blaSHV, blaTEM-63 and blaOXA-10, and other AMR genes, across diverse lineages of the KPN iso-
lates from Malawi. No carbapenem resistance genes were detected; however, we detected IncFII and IncFIB
plasmids that were similar to the carbapenem resistance-associated plasmid pNDM-mar.
Conclusions: There are multiple ESBL genes across diverse KPN lineages in Malawi and plasmids in circulation
that are capable of carrying carbapenem resistance. Unless appropriate interventions are rapidly put in place,
these may lead to a high burden of locally untreatable infection in vulnerable populations.
Introduction
Klebsiella pneumoniae (KPN) is an opportunistic pathogen respon-
sible for a wide range of hospital-associated (HA) infections, mostly
in immunocompromised individuals.1–3 KPN is also increasingly
implicated in community-acquired (CA) infections in healthy indi-
viduals.1,4 The disease syndromes associated with KPN include
pneumonia, bacteraemia, urinary tract infections, wound or soft
tissue infections and liver abscess.1 In the USA, KPN was identified
as a leading cause of HA infections and was estimated to cause
8.0% of all HA infections, while in the UK, KPN was implicated in
4.7%–6.0% of all bacterial infections.5 Sparse data are available
from sub-Saharan Africa (sSA), but published studies do suggest
KPN is responsible for higher proportions of HA infections in this re-
gion than those reported in industrialized countries, especially
among children under 5 years old. In South Africa, KPN caused
22.0% of HA bacteraemia among neonates, whereas in Kenya,
KPN was estimated to be responsible for 20.0% of HA bacter-
aemia.6,7 Additionally, KPN is consistently reported as a common
VC The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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cause of CA infection in sSA. We previously reported that KPN
caused 4.4% of CA bacteraemia over a period of 20 years in Malawi
and is becoming an increasingly important cause of bacteraemia
in children aged,5 years and the elderly.4,8
Health agencies such as WHO and CDC have identified KPN as
an urgent threat to human health due to its ability to rapidly ac-
quire and stably express resistance to multiple antimicrobial
classes, including antimicrobial agents of last resort.1,9,10 This is
particularly challenging in sSA, where the available antimicrobial
classes are fewer than in high-income settings, and cephalospor-
ins are often the antimicrobial of choice, so ESBL-producing patho-
gens present an extreme therapeutic challenge.
Recent WGS studies of global and national collections of KPN
have offered a glimpse of the diversity and antimicrobial resistance
(AMR) associated with this pathogen.9,10 This includes identifica-
tion of hypervirulent and MDR clones such as clonal groups CG258
and CG14, which have caused hospital outbreaks in several coun-
tries in Europe and Asia.11–13 Such studies have further helped us
to understand the mechanisms through which AMR spreads,
whereby both horizontal gene transfer (HGT) and clonal expan-
sions have been identified as the main mechanisms of AMR spread
across various KPN lineages.9–11,14,15 Despite this increasing know-
ledge of the diversity of KPN globally, few studies have included
isolates from sSA and there is, therefore, limited understanding of
the genomic background of AMR in KPN in the region. In Malawi,
the ESBL-producing proportion of KPN has increased to over 90.0%
concurrent with ceftriaxone becoming the antimicrobial agent of
choice for treating severe bacterial infections.4 Such very high rates
could suggest either rapid expansion of a single ESBL-producing
KPN clone or high selection pressure resulting from the increased
use of third-generation cephalosporins driving the spread of ESBL
genes across almost all available KPN lineages. We carried out a
WGS study using KPN isolates from a single site in Malawi to under-
stand the genetic background of ESBL-producing strains in this set-
ting and place them in the context of the global population
structure of KPN.
Methods
Study setting and isolates
We used samples collected as part of routine bacteraemia and meningitis
surveillance at Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi
and archived at the Malawi-Liverpool-Wellcome Trust Clinical Research
Programme (MLW). Isolates were selected with the aim of maximizing AMR
diversity and included invasive isolates (n"59), from blood and CSF, and car-
riage isolates from rectal swabs (n"13). Blood and CSF samples were taken
from adult and paediatric patients presenting to QECH between 1996 and
2014, within 48 h of admission to hospital, and hence isolates were consid-
ered to be CA. Rectal swabs for carriage isolates were collected from adult
patients with no suspected bacterial infection during a prevalence survey
over a period of two weeks in 2009. Antimicrobial susceptibility tests were
performed by the disc diffusion method following BSAC guidelines (www.
bsac.org.uk). Isolates were routinely tested for susceptibility to representa-
tives of six commonly used antimicrobial classes, namely ampicillin, cotri-
moxazole, chloramphenicol, gentamicin, ceftriaxone/cefpodoxime and
ciprofloxacin. Isolate-specific year and clinical site of isolation, phenotypic
AMR profiles and patient age categories are presented in Table S1 (available
as Supplementary data at JAC Online). Whole genome DNA extraction for
selected isolates was done at MLW laboratories using the QIAGEN Universal
Biorobot (Hilden, Germany) following the manufacturer’s instructions.
WGS, de novo assembly and sequence annotation
Genomic DNA was sequenced at the Wellcome Sanger Institute using the
Illumina HiSeq 2000 platform (Illumina, Inc., San Diego, CA, USA) to gener-
ate paired-end sequence reads of 100 bp length. Velvet v1.2.0916 was used
for de novo assembly of sequence reads into contiguous sequences follow-
ing the pipeline by Page et al.17 Sequence assemblies were annotated
in silico using the Prokka v1.11 bacterial annotation pipeline.18 Raw se-
quence data were deposited in the European Nucleotide Archive (ENA) and
ENA accession numbers are included in Table S1.
Published genome datasets
In order to place the genetic diversity and population structure of the
Malawian KPN isolates in a global context, we analysed our sequenced
genomes together with other previously sequenced KPN genomes from
around the world. We selected genome sequences from a study that
defined the global population structure of KPN and another that investi-
gated genomic epidemiology of KPN in Kenya.7,9 The global KPN study iden-
tified that KPN belongs to three major lineages, namely KpI, KpII and KpIII,
and we used cluster random sampling to select 67 human invasive and car-
riage isolates from each of those phylogroups in this global collection. From
the Kenyan collection, 66 isolates were selected systematically as isolate
identifiers were not matched to phylogroups. A list of ENA accession num-
bers for the selected global and Kenyan isolates are included in Table S2.
Phylogeny reconstruction and inference of population
structure
We used the Roary pan-genome pipeline19 to construct a core genome of
the annotated genome assemblies of the 205 isolates included in our ana-
lysis. In trading off between identifying a core genome that is representa-
tive of all the KPN lineages in this collection and accounting for possible
assembly errors, we classified a gene as core if it was conserved in at least
99.0% of the genomes. A core genome alignment was then generated
through concatenation of the alignments of orthologous core genes. Based
on the core genome alignment, we grouped isolates into unique genome
sequence clusters (SCs) using the hierBAPS module in the Bayesian Analysis
of Population Structure (BAPS) v.6.0 software.20 SNP sites were generated
from the core-genome alignment and used to construct a maximum likeli-
hood (ML) phylogenetic tree with RAxML v.7.8.6 under the General Time
Reversible (GTR) substitution model with a gamma rate of correction het-
erogeneity.21,22 The reliability of the inferred branches and branch parti-
tions in the phylogenetic tree was assessed using 100 bootstrap replicates.
Raw sequence reads of isolates belonging to clonal complex 14 (CC14)
from the Malawian collection were mapped to the MLST15 reference strain
(Genbank: CP022127) using SMALT (https://www.sanger.ac.uk/science/
tools/smalt-0) and we performed recombination analysis on the resulting
alignment using Gubbins.23
Table 1. Mean number of pairwise single nucleotide variants by KPN lin-
eage and origin of isolates
Mean pairwise SNP difference (%103)
Origin KpI KpII KpIII
Malawi 11.6 14.7 14.7
Kenya 11.6 73.1 12.7
Outside sSA 12.8 29.8 14.1
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In silico molecular typing of study isolates
We did molecular characterization of the isolates by MLST24 and capsule
polysaccharide typing (K-typing). MLST was performed by a BLAST search
(100% match identity) of sequence assemblies against the PubMLST to
identify the different allelic profiles of each isolate based on seven house-
keeping genes including gapA, infB, mdh, pgi, phoE, rpoB and tonB. Isolates
were K-typed using the Kaptive locus typing and variant evaluation tool
with k-locus searches performed against the Kaptive KPN k-locus reference
database.25
Determination of AMR and plasmid typing
We screened for presence of acquired AMR genes by an automated nucleo-
tide BLAST search of our genome assemblies against a curated ResFinder
database.26 Presence of a gene in an isolate was confirmed if its assembled
sequence had at least 95.0% nucleotide matching identity with a gene
in the database for a coverage of at least 90.0%. We analysed translated
nucleotide sequence alignments of the gyrA, gyrB, parC and parE genes to
identify specific amino acid mutations that were associated with fluoro-
quinolone resistance (FQR). In silico plasmid typing was also performed by a
BLAST search of plasmid replicons against the PlasmidFinder database.27
As with the search for the AMR genes, we used thresholds of 95.0% and
90.0% for nucleotide identity match and match length, respectively.
Statistical analyses
We compared mean pairwise SNP differences between lineages and be-
tween places of origin of isolates using t-tests. v2 tests, where appropriate,
or Fisher’s exact tests were used to test for AMR gene–phenotype associa-
tions and AMR gene–plasmid associations. Linear regression was per-
formed to model the relationship between time and number of AMR genes
per genome. All statistical analyses were performed using the R v.3.3.2 stat-
istical package (https://www.r-project.org/).
Results
Genetic diversity of Malawian KPN isolates
Pan-genome analysis of the 205 KPN genome sequences (72
Malawian and 133 previously published) predicted a total of
32629 unique protein-coding sequences (CDSs); 2449 (7.5%) CDSs
were identified in 99.0% of isolates and so formed the core gen-
ome. The accessory genome, comprising the remaining 30180
CDSs identified in ,99.0% of the isolates, predominantly com-
prised genes that were uncommon, with 26815 (88.9%) being pre-
sent in ,15.0% of the isolates and 12438 (40.2%) that were
isolate specific.
Phylogeny and population structure
The core genome of all 205 genomes had 307392 SNPs.
Phylogenetic and BAPS analyses clustered the isolates into four
SCs, which corresponded to the KPN phylogroups KpI (KPN), KpII-A
and KpII-B (Klebsiella quasipneumoniae) and KpIII (Klebsiella
variicola) (Figure 1a). The majority of Malawian isolates were KpI
[93.1% (67/72)], whereas only three and two isolates were KpII-B
and KpIII, respectively. None of the Malawian isolates belonged
to the KpII-A cluster. Isolates differed in nucleotide diversity
based on the pairwise SNP differences, both by lineage and origin
(Table 1). Comparisons of pairwise SNP differences of KpI isolates
by origin showed that Malawian and Kenyan isolates had similar
nucleotide diversity (Table 1; P"0.7369), which was significantly
lower than the global nucleotide diversity (Table 1; P,0.001).
There was consistency between clustering of isolates based
on shared accessory genes and BAPS SCs based on core SNPs
(Figure 1b). This consistency indicates that genetic differences
occurring through HGT were not sufficient to disrupt the population
structure of KPN either on a local or global scale. Furthermore,
it also shows that HGT was more likely to occur between more
closely related isolates.
When data on year of isolation and clinical source of the KPN
isolates from Malawi were mapped onto a phylogenetic tree of
Malawian isolates only, it was apparent that phylogenetic cluster-
ing of isolates was independent of either the clinical source or year
of isolation (Figure 1c). More importantly, we also noted phylogen-
etic mixing of carriage isolates with invasive isolates, suggesting a
Table 2. Recombination statistics of KPN ST14 and ST15 (CC14) isolates from Malawi. Isolates were mapped to the chromosome sequence of KPN
MLST15 reference strain (Genbank Accession number CP022127)
Isolate ID ST No. of recombination sites No. of recombination blocks Recombination sites/mutation (r/m) Bases mapped
D25597 ST14 0 0 0 5055359
1022430 ST14 0 0 0 5035481
A28 ST14 0 0 0 5002581
8193 ST14 28 1 1.6 5078006
D39172 ST14 347 4 2.4 5021455
1023547 ST14 0 0 0 5035136
D3538 ST14 20 1 0.5 5078081
D44912 ST14 0 0 0 5002012
4604 ST14 0 0 0 5055065
D29665 ST14 0 0 0 5055654
D53369 ST14 1165 9 5.7 5013254
C24a ST15 823 6 16.1 5164584
1007011 ST15 639 2 11.6 5091879
D25466 ST15 335 4 12.9 5097947
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potential role for carriage strains as a reservoir of invasive strains in
the Malawian setting.
Over the past two decades, MLST has become one of the most
important and commonly used methods for characterizing bacter-
ial strains.28 Here we identified STs of the Malawian isolates by
in silico MLST. Mapping these STs to the phylogenetic tree of
Malawian isolates revealed that most SCs were composed of di-
verse STs. We ran hierBAPS again, but only on the core-genome
alignment of KpI SC isolates from Malawi and identified two sub-
clusters; a monophyletic subcluster consisting of mostly ST14 and
a few ST15 isolates, and a polyphyletic subcluster containing iso-
lates with high sequence diversity, whose clustering did not reflect
a common evolutionary history. ST14 and ST15 belong to KPN
CC14 (Figure 1c) and, in this collection, ST14 [11 isolates (15.5%)]
was the most common ST whereas ST15 was the third most com-
mon ST [3 isolates (4.2%)], behind ST664 [4 isolates (5.6%)].
(a) (b)
(c)
C1408
10038396
D50395
D50395
D25597
4604
D29665
D39172
A28
D44912
1022430
1023547
8193
D3538
D53369
C24a
D25466
1007011
D5105
D46208
C35
0.01 SNPs/site
0.0058 SNPs/site
Figure 1. Population structure and genetic diversity of KPN. (a) A phylogenetic tree of Malawian isolates in the context of previously published global
KPN isolates constructed from core SNP alignment and rooted at the middle of the branch separating the two most divergent sequences. (b) A heat-
map illustrating clustering of Malawian and global KPN isolates by accessory genes. (c) Core-genome phylogenetic tree of KPN isolates from Malawi
only, which also shows key STs and K-types and the phylogenetic mixing of isolates from different sources and years of isolation. This figure appears
in colour in the online version of JAC and in black and white in the print version of JAC.
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Except for one isolate, which belonged to the capsular type K16,
the rest of the ST14 isolates belonged to the hypervirulent K-type
K2 (Figure 1c). Diverse and less frequent serotypes were distributed
across the SCs and serotype variations within STs were common
(Table S1).
Recombination events contribute substantially to the evolution
of many bacteria and may confound phylogenetic reconstruc-
tion.29 We attempted to elucidate the role of recombination in the
evolution of the CC14 isolates, which were the most common and
closely related isolates in the Malawian collection. We ran recom-
bination analysis on the genome sequence alignment resulting
from mapping the CC14 isolates to the ST15 reference strain
(Genbank: CP022127). Despite the reference being more closely
related to the ST15 isolates than ST14 isolates, mutations were 15
times more likely to have been acquired through recombination
events in ST15 isolates [mean recombination rate (r/m)"13.5]
Table 3. List of AMR genes identified in genomes of KPN isolates from Malawi
Prevalence
AMR gene Gene description Resistance n %
fosA metalloglutathione transferase fosfomycin 69 95.8
oqxA Oqx efflux pump fluoroquinolones 67 93.1
oqxB efflux pump fluoroquinolones 66 91.7
sul2 sulphonamide resistance dihydropteroate synthase sulphonamides/co-trimoxazole 56 77.8
dfrA dihydrofolate reductase methoxazole/co-trimoxazole 58 80.1
aac(60)-lb-cr acetyltransferase aminoglycoside, fluoroquinolones 53 73.6
blaTEM-1 b-lactamase aminopenicillins 53 73.6
catA acetyltransferase chloramphenicol 53 73.6
strB streptomycin phosphotransferase aminoglycosides 46 63.9
strA streptomycin phosphotransferase aminoglycosides 46 63.9
blaCTX-M-15 ESBL aminopenicillins, cephalosporins 28 38.9
sul1 sulphonamide resistance dihydropteroate synthase sulphonamides/co-trimoxazole 25 34.7
blaSHV-1 b-lactamase aminopenicillins 22 30.6
tet(D) tetracycline efflux tetracyclines 21 29.2
blaSHV-11 b-lactamase aminopenicillins 17 23.6
mphA macrolide phosphotransferase chloramphenicol 16 22.2
tet(A) tetracycline efflux tetracyclines 12 16.7
blaOXA-1 b-lactamase aminopenicillins 11 15.3
aadA2 tetracycline efflux aminoglycosides 11 15.3
blaSHV-28 b-lactamase aminopenicillins 10 13.9
arr ADP-ribosylation catalysing enzyme rifampicin 7 9.7
alph3 aminoglycoside phosphotransferase aminoglycosides 6 8.3
qnrB plasmid-mediated quinolone resistance fluoroquinolones 6 8.3
cmlA1 MFS transporter/chloramphenicol efflux chloramphenicol 5 6.9
floR transmembrane segments efflux chloramphenicol/florfenicol 5 6.9
blaOXA-10 ESBL aminopenicillins, cephalosporins 5 6.9
tet(B) tetracycline efflux tetracycline 5 6.9
qnrs plasmid-mediated quinolone resistance fluoroquinolones 4 5.6
blaSCO-1 b-lactamase aminopenicillins 4 5.6
blaOXA-9 ESBL aminopenicillins, cephalosporins 4 5.6
blaSHV-12 ESBL aminopenicillins, cephalosporins 3 4.2
blaSHV-26 b-lactamase aminopenicillins 3 4.2
blaOKPB b-lactamase aminopenicillins 2 2.8
ereA erythromycin esterase erythromycin 2 2.8
blaSHV-7 ESBL aminopenicillins, cephalosporins 2 2.8
blaTEM-63 ESBL aminopenicillins, cephalosporins 1 1.4
blaLEN-16 b-lactamase aminopenicillins 1 1.4
blaLEN-25 b-lactamase aminopenicillins 1 1.4
blaSHV-133 b-lactamase aminopenicillins 1 1.4
blaSHV-25 b-lactamase aminopenicillins 1 1.4
blaSHV-27 ESBL aminopenicillins, cephalosporins 1 1.4
blaSHV-36 b-lactamase aminopenicillins 1 1.4
blaSHV-37 b-lactamase aminopenicillins 1 1.4
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than in ST14 isolates (mean r/m"0.93; Table 2). We ran this ana-
lysis again, but even after mapping the CC14 isolates to an inde-
pendent ST23 reference strain NTUH-K2044 (GenBank accession
number AP006725), recombination rates were still higher in ST15
than ST14 (Table S3). The frequency of recombination events in
ST14 isolates ranged from zero to nine, whereas in ST15 isolates,
the frequency of recombination events per genome ranged be-
tween two and six (Table 2). Homologous recombination events
have led to the emergence of MDR and hypervirulent clones that
have caused hospital outbreaks in other settings, including ST258,
which emerged from ST11.10 The frequent recombination events in
the Malawian ST15 and some ST14 isolates therefore have poten-
tial to give rise to epidemics of highly resistant KPN in this setting.
AMR
We identified a total of 43 distinct AMR gene alleles, with most
genomes having at least 10 AMR gene alleles (Table 3).
Distribution of AMR gene alleles by lineage showed that KpI and
KpII isolates had relatively similar distributions with both having
an average of 11 AMR genes per genome albeit with substantial
variations between isolates (range 0–19 for KpI and 0–17 for KpII;
Figure 2a). Fewer AMR genes were observed from isolates in KpIII,
although this could be due to the low number of isolates in this
phylogroup. Both isolates in the KpIII lineage carried four AMR
gene alleles, three of which (fosA, oqxA and oqxB) were almost core
to the collection (69/72) and a different variant of a blaLEN gene for
each (Table S1). There were no differences in terms of number of AMR
genes per genome based on clinical source (Figure 2c), indicating that
carriage isolates are a reservoir of AMR genes. Whilst no significant
differences over mean number of AMR gene alleles per genome
were observed over time (Figure 2c; P"0.285), there was a signifi-
cant increase in the maximum number of AMR gene alleles in a gen-
ome per year (Figure 2d; P"0.032), which was consistent with the
steady increase in phenotypic AMR we have previously reported.4
Molecular determinants of ESBL and FQR
Resistance to cephalosporins was conferred by a variety of ESBL-
encoding gene variants. Amongst identified ESBL genes, blaCTX-M-15
P= 0.285
CSF Blood Rectal swab
0
5
10
15
20
Source
N
o.
 o
f A
M
R 
ge
ne
s
pe
r g
en
om
e
K-SC1 K-SC2 K-SC3
0
5
10
15
20
Sequence Cluster (SC)
N
o.
 o
f A
M
R 
ge
ne
s
1996 1998 2000 2005 2007 2009 2011 2013
0
5
10
15
20
Year
N
o.
 o
f A
M
R 
ge
ne
s
pe
r g
en
om
e 
2000 2010
8
10
12
14
16
18
20
Year
M
ax
. N
o.
 o
f A
M
R 
ge
ne
s
pe
r g
en
om
e
1996 1998 2002 2004 2006 2008 2012 2014
Observed
Regression model estimate
95% confidence interval
P= 0.032
(a) (b)
(c) (d)
Figure 2. Distribution of number of AMR genes per genome of KPN isolates from Malawi. The figure shows that the median number of genes per gen-
ome was similar for KpI (K-SC1) and KpII (K-SC3) isolates but KpIII (K-SC2) genomes carried fewer AMR genes (a). Distribution of genes per genome
did not significantly vary based on clinical source of isolation (b) or time (c) but isolates with genomes harbouring higher numbers of genes emerged
in the later years (d).
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was predominant [28/72 (38.9%)] but we also identified blaSHV,
blaOXA-10 and blaTEM-63 genes in a number of isolates (Table 3).
There was 100% concordance between presence of all ESBL genes
and ceftriaxone resistance phenotype (Figure 3b). The blaCTX-M-15
gene was always associated with plasmid sequences of IncFII and
IncFIB types (Figure 3c). The genetic environment of blaCTX-M-15
consisted of the insertion element ISEcp1 upstream of the gene,
similar to what we previously observed in Escherichia coli from the
same setting, raising the possibility of interspecies HGT of this ESBL
gene facilitated by the IncFII and IncFIB plasmids.30
We screened for amino acid substitutions in the QRDRs of gyrA,
parC, gyrB and parE and identified mutations at codon positions
S83I (four isolates), S83F (three isolates) and S80Y (one isolate) in
the amino acid sequence of gyrA and S80I (six isolates) in parC, but
ciprofloxacin resistance was associated with the gyrA mutations
(Figure 3b; P,0.001). Except for the gyrAmutation D87A, which we
only identified in genomes of ST15 isolates, ESBL and FQR geno-
types were not strongly linked to a particular lineage of KPN in
Malawi (Figure 3a). The amino acid substitution D87A was linked to
ST15 isolates, which were all ciprofloxacin resistant.
The collection also contained isolates that had acquired AMR
genes associated with low-level FQR including oqxA/oqxB [67/72
(93.1%) isolates],qnrB [6/72 (8.3%) isolates], qnrS [4/72 (5.6%) iso-
lates] and the aac(60)-Ib-crgene. We found evidence of association
between the presence of qnrB or qnrS genes and ciprofloxacin-
resistance phenotype (P,0.0001). In contrast, oqxA and oqxB
were not associated with ciprofloxacin resistance phenotype in
this collection (P"0.558). This was not surprising, as the presence
of these genes on their own does not necessarily result in resist-
ance, unless overexpressed.31
The majority of the AMR genes were associated with IncFIB and
IncFII plasmids (Figure 3c). The IncFII and IncFIB replicons were
identified in exactly the same isolates and were associated with
exactly the same genes, suggesting either that these two replicons
were on one plasmid or that they each represent different plas-
mids that coexist to provide stability to each other. No carbapenem
resistance genes were detected in the Malawian KPN isolates;
however, some of the IncFII and IncFIB plasmid replicons were al-
most identical (match identity .99.0% and 100.0% coverage)
to those of the carbapenem resistance plasmid pNDM-mar
(Genbank: JN420336.1). We mapped sequence reads of one iso-
late (D25597) to the pNDM-mar plasmid and a pairwise compari-
son of the two plasmid sequences using the Artemis comparison
tool (ACT)32 showed high similarity (Figure 4).
Discussion
KPN is a pathogen of global importance due to its association with
extensive AMR but little is known about the genomics of this patho-
gen in sSA.33,34 In order to expand the understanding of the
(a) (b)
(c)
0.0055 SNPs/site
Figure 3. (a) Distribution of ESBL and FQR genotypes across the phylogenetic tree of KPN isolates from Malawi. The figure reveals that except for the
gyrA mutation at codon position 87, which was associated with ST15, ESBL and FQR genotypes were not restricted to a specific phylogenetic cluster
of isolates. (b) Association between isolates with ESBL or FQR genotype and AMR phenotype. (c) A heatmap illustration of associations between plas-
mid Inc-types and acquired AMR genes present in five or more genomes. Association values were measured as a proportion of the number of isolates
with a plasmid Inc-type to the number of isolates with AMR genes. This heatmap shows that most AMR genes of KPN isolates from Malawi were co-
occurring with IncFIB and IncFII plasmids. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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genomics of MDR KPN in sSA, we placed a KPN collection from
Malawi in the context of other previously sequenced KPN isolates
from Kenya and elsewhere across the globe. We have shown that
the KPN population in Malawi fits well into the global population
structure of KPN but KpI isolates from sSA exhibited less nucleotide
diversity compared with each other than compared with the global
isolates. Whilst the reduced nucleotide diversity in the Malawian
and Kenyan isolates could reflect the fact that isolates were
obtained from single sites, it also suggests that fewer clones are re-
sponsible for KPN infections in sSA than is the case globally. In par-
ticular, we have identified CC14, consisting of mostly ST14 and a
few ST15 isolates, as an important KPN clone associated with inva-
sive disease in Malawi. Within sSA, the predominance of ST14
among invasive KPN isolates is not unique to Malawi, although in
the previous studies it was associated with HA infections. ST14 was
identified as the most common KPN ST causing HA paediatric in-
fection in Tanzania and was also linked to a hospital outbreak in
South Africa.34,35 These findings suggest that KPN ST14 is endemic
to sSA. Furthermore, the similarity in nucleotide diversity between
the Malawian and Kenyan isolates suggests KPN populations in
these two sSA countries are under similar selection pressures.
The spread of MDR and ESBL-encoding genes amongst KPN
strains has been associated with the expansion of a limited
number of KPN epidemic clones.15 In this study, MDR and ESBL
production were associated with diverse isolates and there was
no single particular AMR profile–lineage combination, although
our study was not designed to detect the emergence of epidem-
ic clones. The strong association between the majority of the
AMR genes and a limited number of plasmid replicons, mostly
IncFII and IncFIB, does suggest that a few plasmids may have a
key role in harbouring and disseminating AMR genes. A number
of KPN isolates (including ST14) from Malawi had plasmids with
high sequence similarity to the pNDM-1 plasmid that harbours
the blaNDM-1-encoding gene. The genetic environment neces-
sary for the acquisition, persistence and dissemination of
blaNDM-1 genes is therefore already present in Malawi, should
the evolutionary selection pressure for their emergence,
through dysregulated carbapenem use, be brought to bear on
this population.
The major limitation of this study is that the isolates from
Malawi came from a single site thereby limiting generalizability of
the findings of this study to the country or region. However, the
similarities of our findings with other studies in sSA7,34 show that
our study is more likely representative of the genomic epidemi-
ology of KPN in sSA. In selecting isolates with the aim of enriching
for diversity, we lost the ability to estimate prevalence of different
STs and to study specific STs in depth. However, this approach has
improved the ability to describe the population structure and diver-
sity of KPN associated with MDR in this setting.
We have shown that the KPN population in Blantyre, Malawi
faces selective pressures that are similar to other settings in sSA,
driving spread of multiple AMR genes, including those for ESBLs,
across diverse lineages. The consistency in population structure of
Malawian isolates with the global isolates further shows that
Malawi is connected to the global exchange of circulating MDR KPN
lineages and that these may be causing untreatable infections in a
setting with very limited antimicrobial options. The presence of
plasmids, which have been associated with carbapenemases
Figure 4. A pairwise comparison of plasmid pNDM1JN420336.1, which harbours the carbapenemase-encoding gene blaNDM-1, and a plasmid se-
quence from isolate D25597 from the Malawian KPN collection by the Artemis comparison tool (ACT). Red and blue blocks connect regions that are
conserved between the two plasmid sequences in forward and reverse orientations, respectively. Non-conserved regions between the two plasmid
sequences are connected by white blocks. The overall level of similarity between the two plasmid sequences was 96.6% at 88.4% coverage. This fig-
ure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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globally, is of considerable concern in a context in which carbape-
nems are starting to be used without a robust culture of antimicro-
bial stewardship.
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